Latest News
News
Aptus Clinical enters into a global partnership agreement with Artelo Biosciences
Press Release Artelo Biosciences ENTERS INTO GLOBAL R&D PARTNERSHIP WITH SYNGENE INTERNATIONAL and APTUS CLINICAL for the clinical development of ART27.13 in oncology LA JOLLA, CA – June 5, 2018 – Artelo Biosciences, Inc. (OTCQB: ARTL), a biopharmaceutical company focused…
Read more >CEO gives a talk at the Advanced Therapies & Regenerative Medicine Congress
Aptus Clinical CEO Steve McConchie discusses Aptus Clinical and their role in iMATCH at the World Advanced Therapies & Regenerative Medicine Congress May 2018. https://twitter.com/aptusclinical/status/999983518720712704
Read more >
Aptus Clinical Awarded Part of £7m Government Investment
Manchester-based Aptus Clinical are one of twelve partners receiving government funding to ensure that more patients benefit from a new generation of medicines. Nearly £7m has been awarded to the Innovate Manchester Advanced Therapy Centre Hub (iMATCH) by Innovate UK…
Read more >
Delighted to be part of iMATCH
A recently formed Manchester health consortium, led by The Christie, has been awarded nearly £7 million of funding to ensure more patients benefit from a new generation of disease-fighting drugs for cancer and non-cancer illnesses. Manchester is one of only…
Read more >